Azetidine derivatives as novel gamma-aminobutyric acid uptake inhibitors: Synthesis, biological evaluation, and structure-activity relationship

作者：Faust Mark R; Hoefner Georg; Pabel Joerg; Wanner Klaus T^*

来源：European Journal of Medicinal Chemistry, 2010, 45(6): 2453-2466.

DOI：10.1016/j.ejmech.2010.02.029

• GABA-uptake inhibitors
• GAT-1
• GAT-3
• Azetidine

In this study azetidine derivatives representing conformationally constrained GABA or beta-alanine analogs were evaluated for their potency as GABA-uptake inhibitors. The study comprised derivatives substituted in 2- as well as in 3-position with either an acetic acid moiety or a carboxylic acid function. In addition, azetidine derivatives bearing a tetrazole ring as a bioisosteric substitute for a carboxylic acid group were included. 3-Hydroxy-3-(4-methoxyphenyl)azetidine derivatives were explored as analogs of the known GABA-uptake inhibitor NNC-05-2045 exhibiting an azetidine ring instead of a piperidine ring present in the latter. Both, N-unsubstituted compounds as well as their N-alkylated lipophilic derivatives, were biologically evaluated for their affinity to the GAT-1 and GAT-3 transporters. Azetidin-2-ylacetic acid derivatives provided with a 4,4-diphenylbutenyl or 4,4-bis(3-methyl-2-thienyl)butenyl moiety as lipophilic residue were found to exhibit the highest potency at GAT-1 with IC(50) values of 2.83 +/- 0.67 mu M and 2.01 +/- 0.77 mu M, respectively. The most potent GAT-3 inhibitor among these compounds appeared to be the beta-alanine analog 1-{2-[tris(4-methoxyphenyl)methoxy]ethyl}azetidine-3-carboxylic acid (12d) displaying an IC(50) value of 15.3 +/- 4.5 mu M. Whereas the tetrazole derivatives showed no potency as GABA-uptake inhibitors, the 3-hydroxy-3-(4-methoxyphenyl)azetidine derivatives exhibited moderate affinity to GAT-1 (compound 18b: IC(50) = 26.6 +/- 3.3 mu M) and to GAT-3 (compound 18e, IC(50) = 31.0 +/- 4.7 mu M).

• 出版日期2010-6